4-145627322-G-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_172250.3(MMAA):c.-66+7915G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000197 in 152,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_172250.3 intron
Scores
Clinical Significance
Conservation
Publications
- methylmalonic aciduria, cblA typeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74338 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:1
The MMAA c.-66+7915G>A variant occurs in an intron and results in the substitution of a guanine at nucleotide position c.-66+7915 with an adenine. To our knowledge, this variant has not been reported in the peer-reviewed literature and is not predicted to result in abnormal splicing by the SpliceAI algorithm (PMID: 30661751). This variant is reported in the Genome Aggregation Database in two alleles at a frequency of 0.000131 in the Latino population (version 3.1.2). Based on the available evidence, the c.-66+7915G>A variant is classified as a variant of uncertain significance for methylmalonic aciduria, cblA type. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at